Half of young adults with diabetes have diastolic dysfunctionJune 14, 2020DiabetesCardiologyEndocrinology
EMPA-REG OUTCOME: Empagliflozin cut insulin need in type 2 diabetesJune 13, 2020DiabetesEndocrinology
Half of type 1 diabetes patients with COVID-19 manage at homeJune 12, 2020DiabetesCOVID-19 UpdatesEndocrinology
‘The story unfolding is worrisome’ for diabetes and COVID-19May 28, 2020DiabetesCOVID-19 UpdatesPulmonologyMixed TopicsEndocrinology
New study of diabetes drug for COVID-19 raises eyebrowsMay 1, 2020DiabetesCOVID-19 UpdatesPulmonologyMixed TopicsCardiologyEndocrinology
Inflammatory markers may explain COVID-19, diabetes dynamicApril 15, 2020DiabetesCOVID-19 UpdatesEndocrinology
Dapagliflozin trial in CKD halted because of high efficacyMarch 30, 2020DiabetesNephrologyCardiologyEndocrinology
Keep calm: Under 25s with diabetes aren't being hospitalized for COVID-19March 26, 2020COVID-19 UpdatesDiabetesEndocrinology
FDA advises stopping SGLT2 inhibitor treatment prior to surgeryMarch 18, 2020DiabetesCardiologyEndocrinology
Treating COVID-19 in patients with diabetesMarch 17, 2020DiabetesCOVID-19 UpdatesInfectious DiseasesEndocrinology
